Hsiang-Chun Chen

838 citations
35 papers · 572 · 1 hit paper · h-index 9

Impact in

Papers in

Hsiang-Chun Chen

31 papers receiving 567 citations

Hsiang-Chun Chen's Hit Papers

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial 2021 · 191 citations
1910+1+3Years since publication50100150

Peers

Hsiang-Chun Chen
Comparison fields: 5 of 64
  • Pulmonary and Respiratory Medicine 404
  • Oncology 242
  • Cancer Research 99
  • Molecular Biology 164
  • Radiology, Nuclear Medicine and Imaging 48
Replace Ruth Riisnaes with:
Ruth Riisnaes United Kingdom
Lara K. Boyd United Kingdom
Justin Wahl United States
Anne Patsouris France
Jayeta Chakrabarti United States
Mehdi Fazal United States
Henry Hiep Vo United States
Emma Jernberg Sweden
Megan Hames United States
Andrew Foxley United Kingdom
Hsiang-Chun Chen relative to Ruth Riisnaes United Kingdom Ruth Riisnaes's profile →
Citations per field
00.5×4.3×
Ruth Riisnaes · 1×
Citations per year

Countries citing papers authored by Hsiang-Chun Chen

Since Specialization
Citations

This map shows the geographic impact of Hsiang-Chun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiang-Chun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiang-Chun Chen more than expected).

Fields of papers citing papers by Hsiang-Chun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiang-Chun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiang-Chun Chen. The network helps show where Hsiang-Chun Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Hsiang-Chun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hsiang-Chun Chen Line = papers co-authored together Hsiang-Chun Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2015194
2
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
Hit paper breakdown →
2021191
3 202034
4 202221
5 202321
6 202016
7 202212
8 201910
9 20218
10 20208
11 20187
12 20165
13 20215
14 20155
15 20154
16 20234
17 20224
18 20223
19 20213
20 20162

About Hsiang-Chun Chen

Hsiang-Chun Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 35 papers that have together received 572 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), PARP inhibition in cancer therapy (11 papers), Cancer Genomics and Diagnostics (4 papers), Gastric Cancer Management and Outcomes (4 papers), Metastasis and carcinoma case studies (4 papers), Online and Blended Learning (2 papers), Memory Processes and Influences (2 papers) and Neural and Behavioral Psychology Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (404 citations), Oncology (242 citations), Cancer Research (99 citations), Molecular Biology (164 citations) and Radiology, Nuclear Medicine and Imaging (48 citations). Hsiang-Chun Chen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Karim Fizazi, Fred Saad, Cynthia G. Healy, Johann S. de Bono, Consuelo Buttigliero, Akos Czibere, Niven Mehra, Celestia S. Higano, Marielena Mata and Inge M. van Oort. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Visual Cognition and Consciousness and Cognition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact